Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Dyazide, Maxzide
Synonyms :
Class :
Potassium sparing diuretics and thiazide Combos
Dosage Forms & Strengths Â
Capsule Â
37.5mg/25mg- triamterene/hydrochlorothiazide Â
50mg/25mg – triamterene/hydrochlorothiazide Â
Tablet Â
37.5mg/25mg – triamterene/hydrochlorothiazide Â
75mg/50mg – triamterene/hydrochlorothiazide
1-2 tablets/capsules 37.5mg/25mg (triamterene/hydrochlorothiazide) or
50mg/25mg (triamterene/hydrochlorothiazide) orally every Day
1 tablet 75mg/50mg (triamterene/hydrochlorothiazide) orally every Day
1-2 tablets/capsules 37.5mg/25mg (triamterene/hydrochlorothiazide) or
50mg/25mg (triamterene/hydrochlorothiazide) orally every Day
1 tablet 75mg/50mg (triamterene/hydrochlorothiazide) orally every Day
1 tablet of 75 mg triamterene and 50 mg HCTZ orally every day
1-2 tablets/capsules of 37.5-50 mg triamterene and 25 mg HCTZ orally every day
Adverse drug reactions:  Â
Frequency Not Defined Â
Triamterene Â
Xerostomia Â
Photosensitivity Â
Weaknes Â
Headache Â
Jaundice Â
Diarrhea Â
Nausea Â
Azotemia Â
Dizziness Â
Fatigue Â
Rash Â
Vomiting Â
Hydrochlorothiazide Â
Hyperglycemia Â
Anorexia Â
Stevens-Johnson syndrome Â
Hypotension Â
Dizziness Â
Phototoxicity Â
Toxic epidermal necrolysis Â
Fever Â
Epigastric distress Â
Alopecia Â
Erythema multiforme Â
Glycosuria Â
Hypokalemia Â
Pregnancy warnings:    Â
AU TGA pregnancy category: CÂ
US FDA pregnancy category: CÂ
Lactation:Â
Excreted into human milk is known (hydrochlorothiazide); Unknown (triamterene)Â
Pregnancy Categories:      Â
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.      Â
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.      Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.      Â
Category N: There is no data available for the drug under this categoryÂ
Patient Information Leaflet   Â
Generic Name: triamterene/hydrochlorothiazideÂ
Why do we use triamterene/hydrochlorothiazide?Â
triamterene/hydrochlorothiazide is a Potassium sparing diuretics and thiazide Combos which is used to treat hypertension and edema.Â